Optinose_logo_RGB.png
Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
June 22, 2020 08:30 ET | Optinose, Inc.
YARDLEY, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Ascendis_FINAL_LOGO_7.23.15.png
Ascendis Pharma A/S Announces Presentation of Preclinical Data for TransCon IL-2 β/γ at AACR Virtual Annual Meeting 2020
June 22, 2020 08:30 ET | Ascendis Pharma
- In vitro data demonstrated selective binding and activation of IL-2 β/γ receptor, associated with reduced IL-2 α receptor binding - - Selective expansion and activation of cells in vivo consistent...
PDS-Logo-Final-2.png
PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer
June 22, 2020 08:30 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Rapid Therapeutic Science Laboratories, Inc. Highlighted in Research Report Released by Emerald Equity Research, LLC
June 22, 2020 08:30 ET | Rapid Therapeutic Science Laboratories
DALLAS, June 22, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing CBD aerosol...
5e7bf39659e7c900040d2212_1.png
Endocanna Health Announces New Immune Function Genetics Report
June 22, 2020 08:30 ET | Endocanna Health, Inc.
BURBANK, CA, June 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Endocanna Health, Inc. (“Endocanna” or the “Company”), a research and development biotechnology company specializing in...
MVIS logo (1).jpg
MicroVision Regains Nasdaq Compliance
June 22, 2020 08:30 ET | MicroVision, Inc.
REDMOND, Wash., June 22, 2020 (GLOBE NEWSWIRE) -- MicroVision, Inc. (Nasdaq:MVIS) announced that it has received a letter from Nasdaq confirming that it has regained compliance with Nasdaq’s listing...
allogene.png
Allogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia
June 22, 2020 08:30 ET | Allogene Therapeutics, Inc.
FLT3-Directed AlloCAR T™ Therapy Demonstrated Potent Anti-Leukemic Activity in Pre-Clinical Models Without Evidence of Off-Target Activity  SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE...
veracode-logo.jpg
Veracode Achieves Recognition for Speed and Fit for Developer Workflows with Amazon Web Services DevOps Competency Status
June 22, 2020 08:30 ET | Veracode
BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Veracode, the largest independent global provider of application security testing (AST) solutions, has achieved the Amazon Web Services (AWS)...
Myovant logo_GNW.jpg
Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
June 22, 2020 08:30 ET | Myovant Sciences, Inc.
Priority Review status expected to accelerate review, with a target FDA action date of December 20, 2020 BASEL, Switzerland, June 22, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a...
CrossTower secures $
CrossTower secures $6 million seed funding round on its mission to mainstream digital asset investing and trading
June 22, 2020 08:30 ET | CrossTower
New York, June 22, 2020 (GLOBE NEWSWIRE) -- CrossTower, a new trading platform founded by capital markets veterans on a mission to mainstream digital asset investing and trading, today announced the...